PHARMACEUTICAL TABLET

A method of preparing a pharmaceutical dosage form having a first and second active drug, comprising (a) forming a controlled release core comprising metformin or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable excipient; (b) coating a coating solution on said...

Full description

Saved in:
Bibliographic Details
Main Authors NANGIA AVINASH, KOSITPRAPA UNCHALEE, GOLDFARB ROBERT I, CARDINAL JOHN
Format Patent
LanguageEnglish
Korean
Published 29.12.2010
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A method of preparing a pharmaceutical dosage form having a first and second active drug, comprising (a) forming a controlled release core comprising metformin or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable excipient; (b) coating a coating solution on said controlled release core to form an immediate release coating, said coating solution comprising: (i) pioglitazone or a pharmaceutically acceptable salt thereof; (ii) water; (iii) an organic solvent; (iv) a binder; (v) optionally a surfactant; (vi) optionally a pore forming agent; wherein the ratio of water to organic solvent is 50:50 to 2:98, and the ratio of binder to pioglitazone or the salt thereof is 1:9 to 1:11; wherein said dosage form releases not less than 75% of the pioglitazone or the salt thereof from the dosage form within 0.5 hour when tested in a United States Pharmacopeia (USP) Type 2 apparatus at 75 rpm in 900 ml of simulated intestinal fluid (pH 7.5 phosphate buffer) and at 37°C.
AbstractList A method of preparing a pharmaceutical dosage form having a first and second active drug, comprising (a) forming a controlled release core comprising metformin or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable excipient; (b) coating a coating solution on said controlled release core to form an immediate release coating, said coating solution comprising: (i) pioglitazone or a pharmaceutically acceptable salt thereof; (ii) water; (iii) an organic solvent; (iv) a binder; (v) optionally a surfactant; (vi) optionally a pore forming agent; wherein the ratio of water to organic solvent is 50:50 to 2:98, and the ratio of binder to pioglitazone or the salt thereof is 1:9 to 1:11; wherein said dosage form releases not less than 75% of the pioglitazone or the salt thereof from the dosage form within 0.5 hour when tested in a United States Pharmacopeia (USP) Type 2 apparatus at 75 rpm in 900 ml of simulated intestinal fluid (pH 7.5 phosphate buffer) and at 37°C.
Author KOSITPRAPA UNCHALEE
CARDINAL JOHN
GOLDFARB ROBERT I
NANGIA AVINASH
Author_xml – fullname: NANGIA AVINASH
– fullname: KOSITPRAPA UNCHALEE
– fullname: GOLDFARB ROBERT I
– fullname: CARDINAL JOHN
BookMark eNrjYmDJy89L5WQQDfBwDPJ1dHYNDfF0dvRRCHF08nEN4WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8d5BRgaGBgaGxuYGRsaOxsSpAgDcDSFb
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20100137023A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20100137023A3
IEDL.DBID EVB
IngestDate Fri Jul 19 15:03:14 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20100137023A3
Notes Application Number: KR20107027556
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101229&DB=EPODOC&CC=KR&NR=20100137023A
ParticipantIDs epo_espacenet_KR20100137023A
PublicationCentury 2000
PublicationDate 20101229
PublicationDateYYYYMMDD 2010-12-29
PublicationDate_xml – month: 12
  year: 2010
  text: 20101229
  day: 29
PublicationDecade 2010
PublicationYear 2010
RelatedCompanies ANDRX LABS LLC
RelatedCompanies_xml – name: ANDRX LABS LLC
Score 2.7760422
Snippet A method of preparing a pharmaceutical dosage form having a first and second active drug, comprising (a) forming a controlled release core comprising metformin...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title PHARMACEUTICAL TABLET
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101229&DB=EPODOC&locale=&CC=KR&NR=20100137023A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMU9MM01KNUrTTbMwTtY1SUoy0U1KSTPVNbZIMk8xNk01sEgGbXD29TPzCDXxijCNYGLIge2FAZ8TWg4-HBGYo5KB-b0EXF4XIAaxXMBrK4v1kzKBQvn2biG2LmrQ3jHosCpgB9rFydY1wN_F31nN2dnWO0jNLwgsBzpdD1hFOTIzsIIa0qCT9l3DnED7UgqQKxU3QQa2AKB5eSVCDEzZ-cIMnM6wu9eEGTh8oVPeQCY09xWLMIgGeDgG-To6u4aGgE4xUAhxdPJxDRFlUHZzDXH20AWaHw_3Trx3ELJjjMUYWIAd_VQJBgXQJlAjY5MUYJMmycTYINEyzSjNJNkgFRh4yaC-kiSDDD6TpPBLSzNwGUGXYhhZyjCwlBSVpsoCK9SSJDlwOAAAxtR1zg
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD7MKc43nRMvUwdK34qlTW33UKRXqr2slEz2NpZeQBQ3XMW_70nodE97CzlwSAInJ19yvi8A98ai1lml1nJtaoVMGCMyK2td1kxmlJpeKWbBCc5J-hhOyctMn3XgY8OFETqhP0IcESOqwHhvxH69-r_E8kRt5fqBvWHX8imglie16JiLVSGA9hzLzybexJVc14pyKc2FjavrYYqy92DfQFAowNKrw3kpq-2kEhzDQYb-PpsT6Lwv-9BzN3-v9eEwaZ-8sdlG3_oUBllo54nt-lPKVQxG1HZinw7gLvCpG8rof_43nXmUbw9GO4MuAv3qHEacBKpqpMQjDSOashjXak0KpcLFKzhWuoDhLk-Xu8230AtpEs_j5zS6giO1LctQx0PoNl_f1TUm14bdiDX5BW2meLg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PHARMACEUTICAL+TABLET&rft.inventor=NANGIA+AVINASH&rft.inventor=KOSITPRAPA+UNCHALEE&rft.inventor=GOLDFARB+ROBERT+I&rft.inventor=CARDINAL+JOHN&rft.date=2010-12-29&rft.externalDBID=A&rft.externalDocID=KR20100137023A